Abstract:Besides molecular and phenotypic variations observed in cancer cells, intratumoral heterogeneity also occurs in the tumor microenvironment. Correlative stiffness maps of different intratumor locations in breast tumor biopsies show that stiffness increases from core to periphery. However, how different local ECM stiffness regulates key functions of cancer cells in tumor progression remains unclear. Although increased tissue stiffness is an established driver of breast cancer progression, conclusions from 2D cultures do not correspond with newer data from cancer cells in 3D environments. Many past studies of breast cancer in 3D culture fail to recapitulate the stiffness of a real breast tumor or the various local stiffnesses present in a tumor microenvironment. In this study, we developed a series of collagen/alginate hybrid hydrogels with adjustable stiffness to match the core, middle, and peripheral zones of a breast tumor. We used this hydrogel system to investigate effects of different local stiffness on morphology, proliferation, and migration of breast cancer cells. RNA sequencing of cells in hydrogels with different stiffness revealed changes in multiple cellular processes underlying cancer progression, including angiogenesis and metabolism. We discovered that tumor cells in a soft environment enriched YAP1 and AP1 signaling related genes, whereas tumor cells in a stiff environment became more pro-angiogenic by upregulating fibronectin 1 (FN1) and matrix metalloproteinase 9 (MMP9) expression. This systematic study defines how the range of environmental stiffnesses present in a breast tumor regulates cancer cells, providing new insights into tumorigenesis and disease progression at the tumor-stroma interface. STATEMENT OF SIGNIFICANCE: Applied a well-defined hybrid hydrogel system to mimic the tumor microenvironment with heterogeneous local stiffness. Breast cancer cells tended to proliferate in soft core environment while migrate in stiff peripheral environment. Breast cancer cells shift from glycolysis to OXPHOS and fatty acid metabolism responding to stiff matrix microenvironment. The transcriptomic profile of breast cancer cells altered due to microenvironmental stiffness changes.

Increased stiffness of extracellular matrix enhanced chemoresistance in 3D-bioprinted ovarian cancer model

Osteosarocma progression in biomimetic matrix with different stiffness: Insights from a three-dimensional printed gelatin methacrylamide hydrogel

Mechanomimetic 3D Scaffolds as a Humanized In Vitro Model for Ovarian Cancer

Substrate Stiffness Modulates the Growth, Phenotype, and Chemoresistance of Ovarian Cancer Cells

Three-dimensional Decellularized Tumor Extracellular Matrices with Different Stiffness As Bioengineered Tumor Scaffolds

3D bioprinted breast cancer model reveals stroma-mediated modulation of extracellular matrix and radiosensitivity

3D Bioprinting of Multi-Cellular Tumor Microenvironment for Prostate Cancer Metastasis.

Bioprinted, spatially defined breast tumor microenvironment models of intratumoral heterogeneity and drug resistance

Advances in tumor microenvironment: Applications and challenges of 3D bioprinting

The Role of Matrix Stiffness in Cancer Stromal Cell Fate and Targeting Therapeutic Strategies

Matrix Stiffness-Regulated Growth of Breast Tumo Spheroids and Their Response to Chemotherapy

Phenotypic Basis for Matrix Stiffness-Dependent Chemoresistance of Breast Cancer Cells to Doxorubicin

Heterogeneous Microenvironmental Stiffness Regulates Pro-Metastatic Functions of Breast Cancer Cells.

3D Printed in Vitro Tumor Tissue Model of Colorectal Cancer

Research progress in 3D cell culture model of ovarian cancer tumor microenvironment

3D bioprinted tumor model: a prompt and convenient platform for overcoming immunotherapy resistance by recapitulating the tumor microenvironment

Three-dimensional matrix stiffness modulates mechanosensitive and phenotypic alterations in oral squamous cell carcinoma spheroids

Extracellular Cell Matrix Stiffness-Driven Drug Resistance of Breast Cancer Cells Via EGFR Activation

Targeting extracellular matrix stiffness for cancer therapy

3D bioprinting of an in vitro hepatoma microenvironment model: Establishment, evaluation, and anticancer drug testing

3D Bioprinted Tumor Model with Extracellular Matrix Enhanced Bioinks for Nanoparticle Evaluation.